Phase II study of disitamab vedotin (RC48) in combination with tislelizumab and bevacizumab in patients (Pts) with HER2 alterations locally advanced or metastatic NSCLC: Primary analysis results of ...
Emerging treatments for advanced cholangiocarcinoma: Addressing the knowledge gap. Background: HCC is a leading cause of cancer-related deaths worldwide. LEN is now a first-line treatment option for ...
Dilemma 2: Do I Need Mechanical Circulatory Support? Case Presentation (LM with LVSD) Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is ...
SAN FRANCISCO--(BUSINESS WIRE)--PicnicHealth, a leading patient-centered healthcare evidence generation company, today announced the launch of a new study portal to facilitate faster, more accurate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results